Related Experiment Videos
Involuntary movement disorders associated with felbamate
J M Kerrick1, B J Kelley, B H Maister
1Department of Pharmacy Practice, University of Minnesota, Minneapolis.
Neurology
|January 1, 1995
Insights
Felbamate, an adjunct antiepileptic drug, may cause involuntary movements like choreoathetosis and dystonia in children. Symptoms resolved after discontinuing felbamate, indicating a potential adverse effect.
Area of Science:
- Neurology
- Pediatric Neurology
- Clinical Pharmacology
Background:
- Felbamate is an antiepileptic medication used as an adjunct therapy for specific seizure disorders.
- Understanding the adverse effect profile of antiepileptic drugs in pediatric populations is crucial for safe treatment.
Observation:
- Two pediatric patients experienced new-onset involuntary movements during treatment with felbamate.
- One child presented with choreoathetosis, while the other developed an acute dystonic reaction.
Findings:
- The involuntary movements were directly associated with felbamate administration.
- Discontinuation of felbamate led to the complete resolution of choreoathetosis and dystonic reactions.
- No recurrence of symptoms was observed after stopping the medication.
Implications:
- Felbamate should be used cautiously in children due to the risk of inducing extrapyramidal side effects.
- Clinicians should monitor pediatric patients for involuntary movements when initiating or adjusting felbamate dosage.
- This case series highlights the importance of recognizing and managing drug-induced movement disorders in pediatric epilepsy management.
Abstract:
Two children developed involuntary movements while taking felbamate as an adjunct to their antiepileptic regimen. One exhibited choreoathetosis and the other an acute dystonic reaction. In both children the symptoms resolved with no recurrence after felbamate discontinuance.